Correlation Between SRI TRANG and DOD Biotech

Can any of the company-specific risk be diversified away by investing in both SRI TRANG and DOD Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SRI TRANG and DOD Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SRI TRANG GLOVES and DOD Biotech Public, you can compare the effects of market volatilities on SRI TRANG and DOD Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SRI TRANG with a short position of DOD Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of SRI TRANG and DOD Biotech.

Diversification Opportunities for SRI TRANG and DOD Biotech

0.85

Correlation Coefficient

SRI TRANG  DOD Biotech

Very poor diversification

The 3 months correlation between SRI and DOD is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding SRI TRANG GLOVES and DOD Biotech Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DOD Biotech Public and SRI TRANG is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SRI TRANG GLOVES are associated (or correlated) with DOD Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DOD Biotech Public has no effect on the direction of SRI TRANG i.e., SRI TRANG and DOD Biotech go up and down completely randomly.

Pair Corralation between SRI TRANG and DOD Biotech

Assuming the 90 days trading horizon SRI TRANG GLOVES is expected to under-perform the DOD Biotech. In addition to that, SRI TRANG is 1.09 times more volatile than DOD Biotech Public. It trades about -0.21 of its total potential returns per unit of risk. DOD Biotech Public is currently generating about -0.22 per unit of volatility. If you would invest  166.00  in DOD Biotech Public on December 28, 2024 and sell it today you would lose (40.00) from holding DOD Biotech Public or give up 24.1% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

SRI TRANG GLOVES  vs.  DOD Biotech Public

SRI TRANG GLOVES

Risk-Adjusted Performance

Very Weak

Over the last 90 days SRI TRANG GLOVES has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

DOD Biotech Public

Risk-Adjusted Performance

Very Weak

Over the last 90 days DOD Biotech Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with SRI TRANG and DOD Biotech

The main advantage of trading using opposite SRI TRANG and DOD Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SRI TRANG position performs unexpectedly, DOD Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DOD Biotech will offset losses from the drop in DOD Biotech's long position.

The idea behind SRI TRANG GLOVES and DOD Biotech Public pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.